Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.
Laser Photonics went public on Friday with its IPO, yet LASE stock is getting demolished as shares are down about 40% on the day.
Ainos (AIMD) stock is gaining on Friday after seeing positive results from hamster clinical trials of its Covid-19 treatment.
MULN stock is in the news following updates on its upcoming Five RS electric vehicle and two insider transactions.
Aterian stands to gain tens of millions of dollars in gross proceeds from a share sale. Nevertheless, traders are dumping ATER stock today.
AVCT did contract with a Middle Eastern provider to offer its Kandy UCaaS platform there but speculation on success has gone nowhere.
Arrival finally delivered an electric van, but it may be too late to save ARVL stock and its microfactory promises.
OCGN stock is getting a boost today on news that Ocugen is partnering with Washington University on its Covid-19 vaccine.
Skillz shares are ripping higher on the day, leaving some to wonder if SKLZ stock will be the next short-squeeze trade.
Today, investors in Avenue Therapeutics and ATXI stock have seen impressive gains, as momentum builds for this micro-cap stock.
T2 tests can detect sepsis quickly, but they don't change clinical practice and the company has failed to turn its intellectual property into a profit.
These unknown penny stocks offer a tremendous upside and are likely to gain immensely once the stock market mounts a comeback
Consider these seven names, a mix of growth and value plays, some of the best penny stocks to buy.
While most investors should probably stay away from penny stocks, for hardened gamblers, these ideas may carry upside potential.
VRAX stock is today's big biotech runner as Virax Biolabs launches a potentially crucial test kit in Europe and elsewhere.
As there's far more uncertainty behind its main positive (Lomotif), this may not be enough to counter its many negatives. These include a history of shareholder dilution, as well as delays in its financial filings. With all of this in mind, BBIG stock (which earns a D in my Portfolio Grader) is a no-go situation.